SUNDAY, APRIL 30, 2017

Study shows flu isn’t deterred by acetaminophen

Scientists recently conducted a randomized clinical trial that shows there are no benefits to patients with influenza when they take acetaminophen or paracetamol for their illnesses. Read More »

Cerberus Capital invests $105 million in PaxVax

Cerberus Capital Management recently invested $105 million in PaxVax Inc., a fully integrated specialty vaccine company that prioritizes creating, producing and selling novel vaccines. Read More »

WHO releases latest report for global health goals

The World Health Organization (WHO) recently released the latest comprehensive analysis of worldwide health trends and difficulties that could arise within the upcoming 15 years. Read More »

Heroes of Polio Eradication honored in Abu Dhabi

Abu Dhabi recently hosted the Heroes of Polio Eradication (HOPE) Awards, which honored five individuals for their work in the fight against polio. Read More »

Novartis donates 300 million malaria treatments for children

Novartis, which produces Coartem Dispersible, the first pediatric antimalarial treatment that has been pre-qualified by the World Health Organization, recently sent the treatment to more than 30 countries that are endemic with malaria. Read More »

HIV death rate higher in southern US

Statistics from the Centers for Disease Control and Prevention (CDC) show that the death rates for HIV patients in the southern U.S. are three times higher than the death rates for HIV patients in other regions of the U.S. Read More »

Michigan study shows many hospital workers avoid flu shots

Data gathered by the University of Michigan shows that fewer than 50 percent of U.S. hospitals have mandatory influenza vaccines for their staff. Read More »

CDC officials evaluate US preparedness for Ebola

Health officials have stated that the U.S. is able to treat the Ebola outbreak but is limited by a variety of variables, such as staffing, financial and resource difficulties. Read More »

Cepheid's Xpert Flu+RSV Xpress test gains FDA waiver

Cepheid recently gained a Clinical Laboratory Improvement Amendments (CLIA) waiver from the Food and Drug Administration (FDA) for the company’s Xpert Flu+RSV Xpress test. Read More »

Exposure to toxic chemicals correlates with limited vaccine response

Scientists from the University of Rochester (UR) Environmental Health Sciences Center recently conducted a study that suggests having toxic chemical exposure in early life can inhibit a baby’s vaccine response. Read More »

New leaders join Malaria No More

New leaders recently joined the board of directors at the Malaria No More organization. Read More »

Mozambique adopts Fast-Track Strategy to fight AIDS

Mozambique recently agreed to using the U.N. AIDS Fast-Track Strategy to improve its response against HIV infections across the nation. Read More »

Wistar studies resistance to HIV among some sex workers

Scientists from the Wistar Institute recently conducted a study evaluating whether there may be a correlation or connection between semen exposure and resistance to HIV infection among sex workers. Read More »

Researchers pool data to study flu resistance

University of Zurich researchers recently teamed with scientists from Germany and the U.S. to analyze the flu’s host molecules and find better ways to stop influenza and its spread. Read More »

Trial of H7N9 influenza vaccine boost shows positive results

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have conducted a small clinical trial of a prime-boost for H7N9 influenza vaccines to provoke a better, stronger immune response against the virus. Read More »

WHO publishes annual World Malaria Report

The World Health Organization (WHO) has published the World Malaria Report 2015, giving readers significant details and data about the disease's global impact. Read More »

Mexican health officials approve Sanofi's dengue vaccine

Sanofi Pasteur’s Dengvaxia, the first dengue fever vaccine in the world, recently gained marketing authorization in Mexico. Read More »

BMJ study shows allergic and asthmatic children can benefit from flu vaccine

A recent study from The BMJ shows that the influenza vaccine for children is not likely to cause any allergic reaction if the child has well-controlled asthma, a recurrent wheeze, or an egg allergy. Read More »

Multiple TB strains discovered in Ethiopia

Health professionals recently discovered a wide variety of diverse strains of tuberculosis (TB) in Ethiopia. Read More »

Walgreens weekly data shows Texas hardest hit by flu

Walgreens has released its weekly Flu Index data to show specific flu activity throughout each U.S. state and its markets, ranking them according to the highest incident rates. Read More »